Identification of A 168-kDa Mucosal Antigen In A Subset of Patients With Cicatricial Pemphigoid  by Ghohestani, Reza F. et al.
COMMUNIC ATION 
Identification of A 168-kDa Mucosal Antigen In A 
Subset of Patients With Cicatricial Pelllphigoid 
Reza F. Ghohestani, Jean F. Nicolas, Patricia Rousselle, * and Alain L. Claudy 
D epartment o f Derm'ltology & Institute of H ealth and Medical R esearches (IN SERM), E. H emot Hospital. F-6943 7 Lyon; and 
' Institute for Biology and C hcmistry o f Prote ins , C NRS UPR 41 2, Lyon , Fran ce 
This study describes the presence of antibodies in 
sera from patients with cicatricial pemphigoid spe-
cific for a 168-kDa antigen expressed by buccal mu-
cosa. Six cicatricial pemphigoid sera unreactive with 
epidermal or dermal proteins in immunoblot assay 
were tested on mucosal protein extracts. Four of 
these sera labeled a mucosal 168-kDa antigen (M168) 
under reducing conditions. An additional cicatricial 
pemphigoid serum with circulating antibodies to 
180-kDa bullous pemphigoid antigen (BPAg2) also 
labeled M168. None of these cicatricial pemphigoid 
sera reacted with the a, /3, or l' subunits oflaminin-5. 
Nitrocellulose elution studies showed that the M168 
antigen is a basement membrane antigen and labeled 
I n recent years, efforts have been made to identifY the antigens targeted by autoantibodies in sera from patien ts with cicatricial pemphigoid (CP); BP antigens (Sarret et ai, 1989; Bernard e/ aI, 1992; Niimi e/ ai, 1992; Balding el ai, 1996), and the £x- (Kirtschig el ai, 1995) , and {3-subunits of 
laminin-5 ' were fo und to be recognized by the C P sera . A third 
gro up was repo rted how e ver with circulating antibodies to the 
basem ent m embrane zone (BMZ) that did no t react with the BP 
antigens or laminin-5 (Sarret et ai, 1991; Domloge-Hultsch et ai, 
1994) .. 
Because C P patients have m arked mucosal invol vement (Fine, 
19S5) , w e hypo thesized that the ti ssue distribution of the C P 
antigen in mucosa may be different fro m that in the skin . T herefo re, 
we eva luated the immuno reactivity on buccal mucosa protein 
lysates o f those C P sera that do not react wi th the epidermal or 
dermal extracts. W e report a subset of C P patients with autoanti-
bodies tbat react with the mu cosal extracts and selectively bind to 
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the epidermal side of salt-split skin. Immunoaffinity-
purified anti-M168 antibodies did not bind to the 
230-kDa bullous pemphigoid antigen (BPAgl) or to 
the 180-kDa BPAg2. None of the control sera from 
healthy individuals or from bullous pemphigoid, 
pemphigus vulgaris, or pemphigus foliaceus patients 
reacted with M168. This study demonstrates the spec-
ificity of some cicatricial pemphigoid sera against a 
168-kDa antigen that is different from the laminin-5 
subunits and shares no epitopes with the antigens of 
bullous pemphigoid (BPAgl, BPAg2) or the epider-
molysis bullosa acquisita. Key lVoyds: autoim",,,,tityl 
b"llous diseaseslbenig1l tlmeo"s membmne pempirigoidlbase-
me"t me",bmne. ] Invest Deymatol107:136-139, 1996 
a 168-kDa antigen (M168). T hi s antigen seems to be diffe rent from 
the laminin-5 and shares no epitopes with the BPAg1 (Stanley e/ aI , 
1981), BPAg2 (Diaz el aI, 1990), or the EBA an tigen (Woodl ey e/ 
ai , 1984). TIllS study demonstrates the importance of usin g mucosal 
prote in e xtracts for the furth er characterization of the CP autoan-
tibodies . 
M ATERIALS AN D METH O DS 
Sera All sevcn patien ts cnro lled in tlus study were diagnosed as ha ving C P 
and mct the following criteria: i) mucosal lesions with o r w ithout slcin 
lesions and scar fo rmation , excluding those patien ts with only ocular lesions 
(C han et ai, 1993); ii) positive immunoflu orescence for IgG and C3 along 
the BMZ. Contro ls were obtained from : i) 10 BP patients with circulating 
anti bodies to BPAgl (n = 5) , BPAg2 (n = 4), or bo ch (n = 1) ; ii) one case 
o f EBA with circulating :1I1tibodies to the 290-kDa antigen; iii) two 
pemphigoid ges tationi s pati ents with circulating antibodies to the BPAg2; 
iv) fOllf pemphigus vulgaris patients wi th circulating antibodies to desmo-
glcin-3 (130 kDa) ; v) three pemplugus foliace us patients with autoantibod-
ies to desm oglein-3 (1 60 kDa) ; vi) fo ur patients with other inflammato ry 
skin di scases; and vii) eight hea lthy controls. T he fo llowing antibodies wcre 
also used in this study: i) a human m Ab to BPAg1 (mAb 230) (Peyro n et ai, 
1994) ; ii) a guinea pig polyclo nal an tibody to rBP55 containing thc BPA gl 
im111unodo min:1I1t cpitopcs (Gaucherand et ai, 1995); iii) a rabbi t po lyclo nal 
antibody to lal11inin-5 (Roussell e et ai, 1991) ; iv) a rabbi t po lyclo nal 
anti body to the immunodominant epitopes of the 13PAg2 ectodo main 
(rAb1 80)- lci ndl y provided by Dr. C. Bedone OJld Dr. G. J. Giudice fr0111 
the Department o f Dermato logy, Mcdical College of Wisconsin (Milwau-
kee, WI) (Giudice et ai, 1993); v) a rabbi t polyclonal antibody to collagen 
IV (Institut Pasteur de Lyon , Lyo n, Fr:1I1 ce); and vi) a mousc m Ab 
anti-collagcn VII (Serotee , O xford. England) . 
Sodium Chloride Separation of Skin N o rmal slcin obtained from 
either breast or abdominal reduction was cut into small fra gments (1 X 0 .5 
cm), and incubated fo r 72 h in 1 M N aCl containing 50 JLM phenylmeth-
ylsulfo nyl flu oride (PM SF) and 0.1 M cthylenediamine tetraacetic acid 
(EDT A) at 4°C. The epidermis was then pceled from the dcmlis. 
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Figure 1. IgG antibodies from a subset of patients with CP label a 16S-kDa antigen on mucosal extracts. Antigcnic spccificity of the cicatricial 
pemphigoid sera was dete rmined by immunoblot assay using different antigenic sources. Thc proteins werc scparated by SOS-PAGE and transferred onto 
lutrocellulose membranes. The membranes were then incubated with the patients' sera at 1:100 dilu tion for 1 h at 34°C. The spccific reactivity of the sera 
against the blotted proteins were further revealed by using secondary biotinylated antibodics-streptavidin-alkaline phosphatasc conjugatcs followed by 
10-min incubatio n with 5-bromo-4- chloro-3-indolyl phosphatehutro b lue tetrazolium diluted in H 20 . n) Epidermal extracts. Epidcrm al extraqs were 
obtained fro m no mlal human cultured keratinocytes. Epidermal antigcns of 230 and I SO leDa wcre labcled by a monoclonal antibody to BPAgl (mAb230) 
(Iall" 1), and a polyclo nal antibody to BPAg2 (rAbISO) (lnll e 2) . One of the CP sera labeled the I SO-leDa epidcmlal antigen (Inlle 6) , the other CP sera (Inlles 
4,5,7,8.9,10) or the negative control (Inlle 3) did not react with the ep idermal protein extracts. b) Oemlal extracts. The denllal part of nonnal human skin 
was scparated Ii'om the epidermis after incuba tion with 1. M NaC I containing 50 ,..,M PMSF and 0.1 M EOTA for 72 h at 4°C, and was used for pro~ein 
extraction. The 290-leDa antigen was labeled by a mo noclonal antibody to collagen VII (290 kOa) , none of the CP sera reacted with tlus antigen (Inlles 2- 8) . 
c) BPAg1 recombinant protein (rBP55). rBP5 5 (55 leDa) contains the major antigenic epitopcs ofBPAgl located at ti,e C-terminal end of the protcin. A guinca 
pig polyclonal antibody raised against the BPAgl staincd rBP55 (l nllc 1). whereas the negative control (lnll e 2) and tI,C CP sera (lnlles 3- 9) did not show any 
reactivity w ith rBP5 5. d) Mucosa l extracts. Human bucca l mucosa was incubated with an extraction butter composed ofl 0 mM Tris-HCl (pH 7.S), 2% SOS, 
5% !3-mcrcaptoethanol, 100 ,..,M EOTA, 200 ,..,M pMSF, 5 ,..,M leupeptin , and 5 ,..,M pepstatin for 30 min at 4°C. The protein Iysates of buccal mucosa were 
used under red ucing conditions (with 5% !3-mercaptoethanol) for immunoblot, the lysates were further heated at 100°C for 3 min. mAb230 and rAblS0 
labeled ti,e 230-leDa BPAg1 (lalle 1), and the 'ISO-leDa UPAg2 (lnll" 2), respectively. Negative control serum had no reactivity (Inlle 3), whereas the CP sera 
(Iall es 4,6,7,8) strongly labeled a '16S-leDa antigen , however, two of thc CP sera showed no reactivity with the mucosal protein lysates (Ialles 5,9) . 
Innmunoflllorescence (IF) C irculating anti-BMZ antibodies were de-
tected by IF performed on 4-,..,m cryostat sections of salt-split no rmal human 
skin. The sections were incubated for 30 min at 20°C with the sera (di lu ted 
1 :20), then washed with phosphate-buWered sa line (PBS) and incubated for 
30 min with fi ltered fluoresce in-conjugated rabbit anti-IIl'!lI"n IgG (Oako, 
G lostrup , Denmark) di lu ted 1 :60 in PBS. 
Protein Lysates 
Epidermnl Exlracls Epidermal proteins were obtained from normal human 
cultured keratinocytes by a previously described technique (Ghohestani ci 
ai, 1996). Briefly, the proteins were extracted after incubation for 30 min at 
4°C with an extraction buO:er of 10 mM Tris-HCl , pH 7.S, with 2% SOS 
(sodium dodecyl suLfate), 5% !3-mercaptoethanol, 100 ,..,M EOTA, 200 ,..,M 
PMSF, 1 ,..,M leupeptin (Sigma, St Louis, MO) , and 1 ,..,M pepstatin (Sigma). 
T he preparations (cell and matrix) were then centrifuged for 30 min at 
10,000 X g at 4°C . The supernatant was kept at - 20°C until used. 
Dermnl EXII'ncls After dermal-epidermal separation as described above, 
dermal proteins were extracted with S M urea and 0 .3 M !3-mercaptoetha-
no l in 25 mM Tris buWer (pH 7.S) with 100 ,..,M PMSF and incubated for 45 
min in an agitator (13ioblock, IlI kirch, France) at 4°C. T he tissue remnants 
were removed by centrifugation for 25 min at 13,000 X g at 4°C. 
M llcosnl Exlracts Buccal mucosa specimens were obta.ined fro m oral sur-
gery of patients free of bullous diseases and were kindly provided by Dr. 13. 
Souchere from thc Department of Stomatology and Maxillofacial Surgery, 
E . Herriot Hospital , Lyon. After washing in PBS, the submucosal tiss ues 
were renlovcd, and 1111lcosal tissues \¥crc incubated 'with an extraction 
buffer made up of 10 mM Tris-HCl (1'1-1 7.S), 2% SDS, 5% j3-mercapto-
eth anol , 100 ,..,M EOTA, 200 ,..,M pMSF, 5 ,..,M leupeptin (Sigma), and 5 
,..,M pepstatin (Sigma) for 30 min at 4°C. The Iysates of bucca l mucosa were 
prepared with a I-Iomogenisor-Oispcrser U ltra Turrax (lka, Heidelberg, 
Germany) for 10 min in extraction buWer followed by four repeated cycles 
ofSOJu cation for 30 s pu lsed at 50% efficiency at 4°C. The Iysates were then 
centrifuged at 11 ,000 X g for 30 min , and the supernatant was stored at 
- 20°C for further testing. 
BPAgl Recombinant Protein (rBP 55) A segment of a human cONA 
(1.5 kb) encoding for the C-terminal part of the BPAgl was subc10ned into 
the expression vector pGEX-3X (Pharmacia Biotech, Orsay, France). The 
resulting GST-BP55 recombinant protein encoded by pGEX-3X were then 
exprcssed in Escherichin coli (Strain DH5a) and purified as described 
previously (Gaucherand el nl, 1995). rBP55 contains major immunogenic 
epitopes of BPAgJ, because it is recognized by S5% of BP scra with 
autoantibodies to BPAg1 (Ghohestani ci nl, unpubLished data). 
Laminin-5 Using a two-step procedure, we purified laminin-5 by affinity 
chromatography from culture media of squamous carcinoma cells (SCC25 
cell s) as described previously (Rousselle el nl, 1995) . Briefly. culture 
medium (500 ml) was passed sequentially over 25 m l of gelatin-Sepharos\! 
(Pharmacia Biotech) , and 10 ml ofBM165-Sepharose (Gl fraction of mAb 
to BM165) equilibrated in PBS. Materia l bound to BM165-Sepharose was 
eluted using 1 M acetic acid . Aliquots of peak fractions were analyzed by 
SOS-pAGE and immunoblotting. The fractions containing laminin-5 werc 
pooled, neutrali zed by dialysis against PBS, and kept frozen at - 20°C. 
SDS-Polyacrylamide Gel Electrophoresis and Immllnoblot Assay 
T he mucosal, epidermal, and demla l proteins and also pu'rified lanulun-5 
were separated by SOS- PAGE (6% acrylamide) under reducing conditions 
as previously described (Ghohestani el nl, 1996). SOS-polyacrylamide gel 
electrophoresis (SOS-PAGE) of purified rBP55 was performed in 10% 
polyacrylamide gels. T he proteins were tI,en electrophoretically transferred 
o nto nitrocellulose membranes, which were then sequentially incubated 
w ith: i) 5% dried milk in 10 mM Tris-HCl, 140 mM N aC!, pH 7.4, 
(TBS/Illilk) for 1 h at 37°C; ii) 1:100 dilution of each serum sample in 
TBS/ milk for I h at 37"C; iii) 1 :500 dilution of a biotinylated goat 
anti-human or anti-mouse IgG (Amersham, Buckinghamslure, England) , or 
biotinylated anti-rabbit or anti-guinea pig Ig (Dako." Carpinteri, CA) in 
TBS/milk fo r 30 min at room temperature; iv) 1 :3000 dilution of strepta-
vidin-alkaline phosphatase (Amersham) . intervening washes were per-
formed using TBS O.I %-Tween 20. The antigen / antibody reactions were 
furth er revealed with 5-bromo-4-chloro-3-indolyl phosphate/ nitro blue 
tetrazolium-bulfered substrate tablets (Sigma). 
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Figure 2. M168 corresponds to a DMZ antigen and localizes to the 
epidermal side of salt-split skill. Anti-M168 antibodies were purified 
fi'om the patient serum by using the M 168 band of nitrocellulose membrane 
as an immunoaflinity substrate. Salt-spli t skin section was incubated with 
these purified ,"lti-M168 19Gs for 120 min. Concentrated anti-M168 
antibodies react with the epidermal side of salt-split skin. The level of split 
was contro lled by using a human mAb to BPAgl (mAb230) and a rabbit 
anti-cqllagen IV antibody . mAb230 labeled the epidermal and antibody to 
co llagen IV the dermal sides of sa lt spli t-skin. 
Indirect IF and lmluunoblot of Nitrocellulose hnluunoaffinity 
Purified Serum T he protein bands transferred onto nitrocellulose paper 
were used as immunoafrinity substrates to purify antibodies directed against 
the M 168 as described by O lmsted (1981). After transfer of proteins of the 
mucosal extracts onto a nitrocellulose membrane, lanes from both sides of 
the membrane were cut out and immunochemically stained with the serum 
to identify the band of interest. Horizontal strips of nitrocellulose containing 
the antigen of interest were then cut, and sera were applied at a 1:5 dilution 
in PBS for 2 h. After washi.ng in P13S-Tween 20, the antibodies were eluted 
in 20 mM sodium citrate (pH 3.2), 0.04% Tween 20, for 3 min at 37°C and 
then immediately neutralized with 2 M Tris-HCI (pH 7.5). The solu tion 
was th'en dialyzed against the buifer, concentrated, and used in IF and 
immul'loblot assays. 
RESULTS 
Autoantibodies From CP Patients Label A 168-kDa Mucosal 
Antigen (M168) Four of six CP sera that did not label proteins of 
epidermal (Fig la) or dermal extracts (Fig 111) stained a 168-kDa 
antigen of buccal mucosa extracts (Fig ld), whereas mAb230 and 
rAb180 labeled the 230- and 180-kDa BP antigens, respectively, on 
blots of both mu cosa l and epidermal extracts. An additional CP 
serum with IgGs to BPAg2 also labeled M168 on blots of 
mu cosa l Iysates. None of the CP sera labeled rBP55, a BPAg1 
recombinant protein containing the C -terminal end of the 
protein (Fig lc); none of the control se ra reacted with rBP55 
(Fig lc) or M168 (Fig ld) . 
In order to characterize the M168 antigen more precisely, we 
recovered highly specific preparations of anti-M 168 antibodies 
using nitrocellulose blots of buccal mucosal extracts as an aft'inity 
substrate for antibody purification . Antibodies e luted from the 
168-kDa band strongly labeled the 168-kDa mucosal antigen (data 
not shown). These affinity-purified M 168 antibodies stained in IF 
the BMZ of skin and mucosa and the epidermal side of salt-split 
skin (Fig 2), conflrllling that the M 168 antigen is a normal 
constituent of th e human BMZ. 
M168 Antigen Is Different from BP Antigens and Laminin-5 
To further test whether M168 shares any epitopes with the BPAgl 
or BPAg2, we recovered the affinity-purified M168 antibodies from 
the 168-kDa band of mucosal extracts. These highly concentrated 
anti-M168 antibodies did not react with the BPAgl (230 ldJa) or 
THE JOUI1..NAL OF INVESTIGATIVE DERMATOLOGY 
BPAg2 (180 kDa) on blots of epidermal extracts, but stained a faint 
band of about 168 kDa (Fig 3). 
To further address whether M168 could be related to lam inin-5, 
we tested the reactivity of our CP sera against purified human 
laminin-5 by immunoblot assay. A rabbit polyclonal antibody 
specific for laminin-5 stained five bands corresponding to the (X-
(165 and 200 kDa), f3- (140 kDa), and 'Y- (155 and 105 kDa) 
subunjt~ (Fig 4). None of th e CP sera reacted with any of these 
polypeptides, suggesting that M168 is distinct fr0111 lamin in-5. 
DISCUSSION 
In the current study, we demonstrate a subset of patients with CP 
that recognize a new BMZ antigen of 168 kDa unrelated to the 
other previously reported antigens involved in subepithelial blister-
ing diseases, i.e., BPAg1, BPAg2, laminin-5 , and the EBA antigen. 
T he M 168 antigen is strongly expressed in the bu ccal ml1cosa but is 
also found at the epidermal BMZ, although to a lesser extent. 
Indeed, affinity-purified anti-M1 68 antibodies, but not whole CP 
sera, r.,intly stained the antigen in epidermal extracts. Th is obser-
vation suggests that the lack of reactivity of CP sera with epidermal 
extracts is due to a low concentration of M 168 antigen in epidermis 
and hence demonstrates the importance of using a mucosal sub-
strate, i.e., buccal mucosa Iysates, for further characterization of 
specific antibod ies in CPo C irculatin g anti-BMZ antibodies are 
routinely detected in only 10-30% of CP sera (Bean , 1974; 
Nisengard e( ai, 1975; Fine elal, 1984). This is in contrast to BP sera, 
in which anti-BMZ antibodies could be detected in about 75-80% 
of cases (Huigol el ai, 1995; Ghohestani e( ai, 1996). Considering 
the predilection for mucosal involvement in CP (Venning et ai, 
1988), it was postulated that circulating anti-BMZ antibodies may 
have more affinity for the buccal mucosa than for skin (Fine et ai, 
1984; Kelly and Wojnarowska, 1988) . This is in agreement with 
our results showing that four of six CP sera nonreactive with the 
skin lysates did react with human mucosal extracts . 
Furthermore, our data provide more evidence for the heteroge-
neity of antigens targeted by CP sera , because CP antibodies may 
bind to at least five distinct antigens: BP antigens 1 and 2 (Sarret et 
ai, 1989; Bemard ef ai, 1992; Niimi elal, 1992; Balding elal, 1996), 
the Ct- (Kirtschig et ai, 1995), and J3-subunits oflaminin-5J and the 
M168 antigen. In this regard, we found a case of CP with 
autoantibodies directed against both BPAg2 and M 168. The M168 
antigen appears to be distinct from BPAg2 (l80 kDa), because it has 
a molecular mass of 168 kDa and because eluted antibodies from 
the 168-kDa band do not react with BPAg2 in immunoblots. The 
polyc1onality of th e autoimmune response with the presence of 
antibodies to distinct antigens could be considered as a possibility in 
this case, as has been already reported in pemphigus. 2 
Recently, lal11inin-5 (epiligrin/blinin/nicein), a major human 
keratinocyte integrin ligand (Verrando el ai, 1988; Carter el ai, 
1991; Rousselle el ai, 1991), has been shown to be the target 
antigen in a subset of patients with CP (Domloge-Hultsch e( ai , 
1992). These patients possess autoantibodies that il11munoprecipi-
tate laminin-5 subunits from human keratinocyte culture media . 
Unlike anti-M 168 sera, circu lating antibodies from these patients 
bound only to the dermal side of sa lt- spli t skin . By iml11unoblot 
assay, we showed that M 168 is different frOI11 laminin-5 , because 
anti-M1 68 antibodies did not react with any laminin-5 subunits, but 
we cannot formally exclude the possibility that it represents a novel 
isoform of larninin . 
Interestingly, Domloge-Hultsch et al (1994) reported the exis-
tence of two different gro!Jps of patients w ith CP. Among 16 
patients studied, six patients' sera contained circu lating IgG reactive 
with the dermal side of salt-split skin that immunoprecipitated 
2 Gbohestani R, NicolasJF, Cozzal1.i E, ThivoletJ, Claudy A: Pemphigus 
superficiali s. Presence of autoantibodies to distinct desmosomal antigens in 
a patient.) II/vesl Dcr/llalol 104:161,1995 (abstr.) . 
VOL. 107, NO. JULY 1996 
230kD-
ISOkD_ 
234 
Figure 3. M168 is different from BPAgl and BPAg2. To show 
whether anti-M 168 antibodies cross-react with the other skjn antigens. we 
ran an immunoblot using a hjgh concentrated purified antibodies to M 168. 
Anti-M168 antibodies wcre eluted from the 168-kDa band of mucosa l 
extracts by 20 mM sodium citrate (pH 3.2). 0.04% Tween 20 iml11ediate ly 
neutralized by 2 M Tris-HCl (pH 3.2) . Thcse affinity purified antibodies did 
not react with the 230-kDa BPAg1 (lall e I). or 180-kDa BPAg2 (/alle 2) in 
an il11munoblot of human cultured keratinocytes, but they labeled a f.1 in t 
band of abo lit 168 kDa (lall e 4). A serum ["om a nOl'lnal hea lthy control did 
not show any reactivi ty (lall c 3). 13PAgl and BPAg2 were stained by two BP 
sera with antibodies against the 230-kDa BPAgl (lall c 1) and ISO-kDa 
BPAg2 (lall e 2). respectively . 
laminin-S; ten other patients with Ig and C3 deposits a t the BMZ of 
buccal l11u cosa did not il11l11unoprecipitate 1aminin-S or any other 
specific antigens frol11 hUl11an k e ratinocytes c ulture media. Because 
these patients had circ ulating antibodies staining the epidermal side 
of salt-split skin, w e hypothes ize that their se ra could be spec ific for 
the M168 antigen. 
The nature of the M168 antigen and its relation with the othe r 
BMZ antigens is presently unknown. Further inve stigations su ch as 
bioc hemical characteriza tion and purifIcation of the M 168 and 
cloning of the responsible gene will revea l the ide ntity of the 
antigen and l11ay contribute to a b etter und erstanding of its 
involve m e nt in basement m e mbrane pathology. 
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Figure 4. Anti-M168 antibodies do not label the H-, /3-, or ')I-sub-
units of laminin-5. Purified laminin-5 was fi rst reduced with S'X, {3-mer-
captoe th'lI1ol , then separated on (j'y" SDS-PA GE and transferred onto 
nitrocellulose membranes. Nitrocellulose membranes were further incu-
bated with a 1: 1 00 dil ution of the human se ra or rabbit an tibody. Five 
polypeptides corresponding to the (\'- (200 and 165 kDa). {3- (140 kDa). and 
')I-subunits (155 and 105 kDa) of laminin-5 were stained by a rabbit 
anti-laminin-5 polyclonal antibody (If/li e 1) , but not by a rabbit 110rmal 
control serum (lall e 2). None of our C P sera reacted with these laminin-5 
sublll~its (/all es 3-9). 
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